MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms
暂无分享，去创建一个
A. La Salvia | R. García-Carbonero | S. Molina-Pinelo | P. Jiménez-Fonseca | B. Rubio-Cuesta | L. Gomez-Izquierdo | M. Benavent | M. Riesco-Martinez | C. Robles | B. Soldevilla | P. Espinosa-Olarte | B. Anton-Pascual | A. Lens-Pardo | M. Fierro-Fernández | C. Carretero-Puche | Y. Rodriguez-Gil | P. Morales-Burgo | Ana Teijo-Quintans | B. Antón-Pascual